Browsing: Pharma

Facing patent cliffs threatening billions in revenue, pharma leaders must embrace 2026 trends in AI drug discovery, biopharma manufacturing, clinical pipelines, and FDA approvals to drive innovation.

China has approved the world’s first commercial brain-computer interface. AstraZeneca is building a new cell…

CSL Behring says the last available hemophilia gene therapy will be temporarily unavailable. HemGenix, CSL’s…

Still basking in the afterglow of launching Wegovy tablets earlier this year, Novo has scored…

To expand its reach in the ADHD market, Collegium Pharmaceutical has entered into an agreement…

AlphaSigma’s buzzer-beater bet on GSK’s prospects for rare liver diseases has paid off. Last week,…

Following a major investment in China, AstraZeneca on Thursday announced plans to build a commercial…

Pfizer is eyeing early use of its PARP inhibitor Tarzenna after positive results in a…

Many of President Donald Trump’s campaign promises to lower drug prices in the United States…

Shares of Indianapolis drugmaker Eli Lilly have fallen more than 7% since investment bank HSBC…